Dual-tracer 18F-FDG and 18F-FLT PET/CT for differentiating metastatic lymph nodes from sarcoid involvement in a patient with vulvar squamous cell carcinoma and coexisting pulmonary sarcoidosis
Authors:
- Junichi TsuchiyaJTJunichi Tsuchiya
- Xiaotong WuXWXiaotong Wu
- Anna TabeiATAnna Tabei
- Momo WakuiMWMomo Wakui
- Hirofumi YamadaHYHirofumi Yamada
- Kota YokoyamaKYKota Yokoyama
- Noriko OshimaNONoriko Oshima
- Kimio WakanaKWKimio Wakana
- Naoyuki MiyasakaNMNaoyuki Miyasaka
- Ukihide TateishiUTUkihide Tateishi
Open Access
- 30 August 2026
- journal article
- Published by Elsevier in Radiology Case Reports
- Vol. 21 (11) , 5680-5684
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Sarcoidosis misdiagnosed as pulmonary malignancy: a case reportFrontiers in Oncology, 2026
- Recent Advances in PET and Radioligand Therapy for Lung Cancer: FDG and FAPCancers, 2025
- In Vivo Fibroblast Activation of Systemic Sarcoidosis: A 68Ga-FAPI-04 PET/CT Imaging StudyDiagnostics, 2023
- Comparative evaluation of 18F-FLT and 18F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosisEJNMMI Research, 2017
- 18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Diagnostic Usefulness of Fluorine–18-α–Methyltyrosine Positron Emission Tomography in Combination With 18F-Fluorodeoxyglucose in Sarcoidosis PatientsChest, 2007
- [18F]FLT-PET in oncology: current status and opportunitiesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Potential impact of [ 18 F]3'-deoxy-3'-fluorothymidine versus [ 18 F]fluoro-2-deoxy-d-glucose in positron emission tomography for colorectal cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003